MedTrace Logo

Study of Efficacy and Safety of Ginger Extract Compared With Loratadine for Treatment of Allergic Rhinitis

NCT02576808 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2017-10-10

No results posted yet for this study

Summary

Efficacy and adverse effects of Ginger extract in treating allergic rhinitis patients compared with Loratadine.The double blind randomized controlled trial study was approved by the Human Research Ethics Committee of Thammasat University NO.1.

Conditions

  • Rhinitis,Allergic

Interventions

DRUG

Ginger extract

Ginger extract capsule at dose of 250 mg two times a day after meal daily for 42 days

DRUG

Loratadine

Loratadine tablet at dose of 10 mg one times a day after morning meal daily for 42 days

Sponsors & Collaborators

  • Thammasat University

    collaborator OTHER

  • Thai Traditional Medical Knowledge Fund

    lead OTHER_GOV

Principal Investigators

  • Rodsarin Yamprasert · Faculty of Medicine Thammasat University (Rangsit Campus)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2017-10-31
Completion
2017-10-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02576808 on ClinicalTrials.gov